FDA: Draft guidance issued on abuse-deterrent opioids
(HealthDay)—The U.S. Food and Drug Administration has issued a draft guidance document to assist the pharmaceutical industry in developing new formulations of opioid drugs with abuse-deterrent properties.
Jan 10, 2013
0
0